Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide Retreatment for GI Vascular Malformation
NCT02301949Phase 2Withdrawn
- Start
- Dec 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in gastrointestinal vascular malformation. Planned start Dec 2015; status: withdrawn.
02
Drugs
thalidomide
03
Conditions
gastrointestinal vascular malformation
Beyond the preview
Go deeper on NCT02301949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301949.